Items Tagged ‘genomic test’

September 8th, 2014

Molecular Subtyping Can Improve Breast Cancer Treatment


IRVINE, CA and AMSTERDAM – In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared to the use of conventional IHC-FISH pathology tests. The prospective observational study of […]

View full entry

Tags: Breast Cancer, diagnosis, genomic test, News, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer, subtype